ArticleJAMA pediatrics2026
Medicaid Expansion and 1-Year Mortality Among Young Adults Initiating Dialysis.
Article in JAMA pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond paediatric nephrology: gaps in care for young adults.Nature reviews. Nephrology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
Importance: The Affordable Care Act (ACA) provided continued Medicaid coverage to US children transitioning into young adulthood, but whether expansion averted deaths among younger adults with kidney failure remains unclear. Objective: To examine the association of Medicaid expansion with 1-year mortality among young adults with kidney failure initiating dialysis. Design, Setting, and Participants: This cohort study using a quasi-experimental difference-in-differences design compared changes in outcomes before and after Medicaid expansion between patients aged 19 to 23 years (affected by expansion) and patients aged 14 to 18 years (comparison group with unchanged eligibility). The study period extended from January 1, 2010, to December 31, 2019. Data analysis was performed from January 2023 to February 2025. Exposure: Medicaid expansion under the ACA. Main Outcomes and Measures: The primary outcome was 1-year mortality from the date of dialysis initiation. Secondary outcomes were Medicaid coverage, uninsurance, predialysis nephrology care, prescribed hemodialysis duration, modality of dialysis, and catheter use at hemodialysis initiation. Results: Among 7139 patients in expansion states, 2348 were 14 to 18 years old (1280 male [54.5%]; 1068 female [45.5%]), and 4791 were 19 to 23 years old (2717 male [56.7%]; 2074 female [43.3%]. One-year mortality for 19- to 23-year-olds declined from 3.6% (95% CI, 2.4% to 4.9%) in the pre-expansion period to 2.1% (95% CI, 1.2% to 3.0%) after expansion (change, -1.5 percentage points; 95% CI, -2.5 to -0.6), while for 14- to 18-year-olds, the concurrent mortality rate was 0.7% (95% CI, 0.3% to 1.0%) pre-expansion and 1.1% (95% CI, 0.5% to 1.7%) postexpansion (change, 0.4 percentage points; 95% CI, -0.3 to 1.1). The adjusted difference-in-difference estimate was -1.8 percentage points (95% CI, -2.9 to -0.7). Medicaid coverage for 19- to 23-year-olds increased from 37.1% to 48.5% and uninsurance rates declined from 19.4% to 7.8%. After accounting for concurrent changes among 14- to 18-year-olds, the adjusted difference-in-difference estimates were 8.4 percentage points (95% CI, 4.8 to 12.0) for Medicaid and -9.1 percentage points (95% CI, -12.4 to -5.8) for uninsurance. Medicaid expansion was associated with higher rates of predialysis nephrology care, prescribed hemodialysis sessions of 4 or more hours, and use of peritoneal dialysis, but not associated with use of catheters for hemodialysis or kidney transplant rates. Conclusions and Relevance: This study found that Medicaid expansion was associated with reductions in 1-year mortality among young adults with kidney failure initiating dialysis. Policy changes to health insurance programs may affect survival for young adults with this highly morbid condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.